Antiproliferative effects by Let-7 repression of high-mobility group A2 in uterine leiomyoma
- PMID: 18403645
- DOI: 10.1158/1541-7786.MCR-07-0370
Antiproliferative effects by Let-7 repression of high-mobility group A2 in uterine leiomyoma
Abstract
High-mobility group A2 (HMGA2) is commonly overexpressed in large leiomyomas. HMGA2 is an important regulator of cell growth, differentiation, apoptosis, and transformation. As a predicted target of Let-7 microRNAs (Let-7s), HMGA2 can be repressed by Let-7s in vitro. MicroRNA profiling analysis revealed that Let-7s were significantly dysregulated in uterine leiomyomas: high in small leiomyomas and lower in large leiomyomas. To evaluate whether Let-7 repression of HMGA2 plays a major role in leiomyomas, we analyzed the molecular relationship of HMGA2 and Let-7s, both in vitro and in vivo. We first characterized that exogenous Let-7 microRNAs could directly repress the dominant transcript of HMGA2, HMGA2a. This repression was also identified for two cryptic HMGA2 transcripts in primary leiomyoma cultures. Second, we found that the endogenous Let-7s were biologically active and played a major role in the regulation of HMGA2. Then, we illustrated that Let-7 repression of HMGA2 inhibited cellular proliferation. Finally, we examined the expression levels of Let-7c and HMGA2 in a large cohort of leiomyomas (n = 120), and we found high levels of Let-7 and low levels of HMGA2 in small leiomyomas, and low levels of Let-7 and high levels of HMGA2 in large leiomyomas. Our findings suggest that the Let-7-mediated repression of HMGA2 mechanism can be an important molecular event in leiomyoma growth.
Similar articles
-
Decreased expression of early growth response-1 and its role in uterine leiomyoma growth.Cancer Res. 2004 Jul 1;64(13):4677-84. doi: 10.1158/0008-5472.CAN-03-0560. Cancer Res. 2004. PMID: 15231681
-
Aberrant expression of HMGA2 in uterine leiomyoma associated with loss of TSC2 tumor suppressor gene function.Cancer Res. 2002 Jul 1;62(13):3766-72. Cancer Res. 2002. PMID: 12097287
-
Loss of let-7 binding sites resulting from truncations of the 3' untranslated region of HMGA2 mRNA in uterine leiomyomas.Cancer Genet Cytogenet. 2010 Jan 15;196(2):119-23. doi: 10.1016/j.cancergencyto.2009.09.021. Cancer Genet Cytogenet. 2010. PMID: 20082846
-
Genomics of uterine leiomyomas: insights from high-throughput sequencing.Fertil Steril. 2014 Sep;102(3):621-9. doi: 10.1016/j.fertnstert.2014.06.050. Epub 2014 Aug 5. Fertil Steril. 2014. PMID: 25106763 Review.
-
HMGI(Y) and HMGI-C dysregulation: a common occurrence in human tumors.Adv Anat Pathol. 1999 Sep;6(5):237-46. Adv Anat Pathol. 1999. PMID: 10472377 Review.
Cited by
-
MiRNAs-mediated cisplatin resistance in breast cancer.Tumour Biol. 2016 Oct;37(10):12905-12913. doi: 10.1007/s13277-016-5216-6. Epub 2016 Jul 22. Tumour Biol. 2016. PMID: 27448297 Review.
-
MicroRNA and cancer--focus on apoptosis.J Cell Mol Med. 2009 Jan;13(1):12-23. doi: 10.1111/j.1582-4934.2008.00510.x. J Cell Mol Med. 2009. PMID: 19175697 Free PMC article. Review.
-
MicroRNA-dependent genetic networks during neural development.Cell Tissue Res. 2015 Jan;359(1):179-85. doi: 10.1007/s00441-014-1899-4. Epub 2014 May 28. Cell Tissue Res. 2015. PMID: 24865244 Free PMC article. Review.
-
Metformin alleviates breast cancer through targeting high-mobility group AT-hook 2.Thorac Cancer. 2020 Mar;11(3):686-692. doi: 10.1111/1759-7714.13318. Epub 2020 Feb 7. Thorac Cancer. 2020. PMID: 32031335 Free PMC article.
-
Phthalate Exposures and MicroRNA Expression in Uterine Fibroids: The FORGE Study.Epigenet Insights. 2020 Feb 18;13:2516865720904057. doi: 10.1177/2516865720904057. eCollection 2020. Epigenet Insights. 2020. PMID: 32128507 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials